The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Platelet Rich Plasma (PRP)-Global Market Insights and Sales Trends 2025
Synopsis
Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue.
The global Platelet Rich Plasma (PRP) market size is expected to reach US$ 625.5 million by 2029, growing at a CAGR of 11.2% from 2023 to 2029. The market is mainly driven by the significant applications of Platelet Rich Plasma (PRP) in various end use industries. The expanding demands from the Orthopedic Surgery, Cosmetic Surgery, General Surgery and Other Surgeries, are propelling Platelet Rich Plasma (PRP) market. P-PRP, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the L-PRP segment is estimated at % CAGR for the next seven-year period.
Global Platelet Rich Plasma key players include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, etc. Global top four manufacturers hold a share about 75%.
North America is the largest market, with a share about 55%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, P-PRP is the largest segment, with a share over 60%. And in terms of application, the largest application is Orthopedic Surgery, followed by Cosmetic Surgery, General Surgery, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Platelet Rich Plasma (PRP), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Platelet Rich Plasma (PRP) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Platelet Rich Plasma (PRP) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Platelet Rich Plasma (PRP) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Platelet Rich Plasma (PRP) covered in this report include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, Arthrex, Exactech, Emcyte Corporation, Arteriocyte and Adilyfe, etc.
The global Platelet Rich Plasma (PRP) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Exactech
Emcyte Corporation
Arteriocyte
Adilyfe
Global Platelet Rich Plasma (PRP) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Platelet Rich Plasma (PRP) market, Segment by Type:
P-PRP
L-PRP
L-PRF
Global Platelet Rich Plasma (PRP) market, by Application
Orthopedic Surgery
Cosmetic Surgery
General Surgery
Other Surgeries
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Platelet Rich Plasma (PRP) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Platelet Rich Plasma (PRP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Platelet Rich Plasma is a biologic isolated from whole blood that is preferentially enriched for platelets. While platelets are the primary component of PRP, preparations may also contain other cellular components such as white blood cells (WBCs) and peripheral stem cells. These components all play a biological role in the healing process and are provided at concentrated levels in PRP. Thus, PRP may help optimize the conditions for healing of bone and soft tissue.
The global Platelet Rich Plasma (PRP) market size is expected to reach US$ 625.5 million by 2029, growing at a CAGR of 11.2% from 2023 to 2029. The market is mainly driven by the significant applications of Platelet Rich Plasma (PRP) in various end use industries. The expanding demands from the Orthopedic Surgery, Cosmetic Surgery, General Surgery and Other Surgeries, are propelling Platelet Rich Plasma (PRP) market. P-PRP, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the L-PRP segment is estimated at % CAGR for the next seven-year period.
Global Platelet Rich Plasma key players include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, etc. Global top four manufacturers hold a share about 75%.
North America is the largest market, with a share about 55%, followed by Asia-Pacific and Europe, both have a share over 40 percent.
In terms of product, P-PRP is the largest segment, with a share over 60%. And in terms of application, the largest application is Orthopedic Surgery, followed by Cosmetic Surgery, General Surgery, etc.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Platelet Rich Plasma (PRP), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Platelet Rich Plasma (PRP) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Platelet Rich Plasma (PRP) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Platelet Rich Plasma (PRP) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Platelet Rich Plasma (PRP) covered in this report include Harvest Technologies, DePuy Synthes, Stryker, Zimmer Biomet, Arthrex, Exactech, Emcyte Corporation, Arteriocyte and Adilyfe, etc.
The global Platelet Rich Plasma (PRP) market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Harvest Technologies
DePuy Synthes
Stryker
Zimmer Biomet
Arthrex
Exactech
Emcyte Corporation
Arteriocyte
Adilyfe
Global Platelet Rich Plasma (PRP) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Platelet Rich Plasma (PRP) market, Segment by Type:
P-PRP
L-PRP
L-PRF
Global Platelet Rich Plasma (PRP) market, by Application
Orthopedic Surgery
Cosmetic Surgery
General Surgery
Other Surgeries
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Platelet Rich Plasma (PRP) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Platelet Rich Plasma (PRP) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Platelet Rich Plasma (PRP) Market Overview
1.1 Platelet Rich Plasma (PRP) Product Overview
1.2 Platelet Rich Plasma (PRP) Market Segment by Type
1.2.1 P-PRP
1.2.2 L-PRP
1.2.3 L-PRF
1.3 Global Platelet Rich Plasma (PRP) Market Size by Type
1.3.1 Global Platelet Rich Plasma (PRP) Market Size Overview by Type (2018-2029)
1.3.2 Global Platelet Rich Plasma (PRP) Historic Market Size Review by Type (2018-2023)
1.3.3 Global Platelet Rich Plasma (PRP) Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Platelet Rich Plasma (PRP) Sales Breakdown by Type (2018-2023)
1.4.2 Europe Platelet Rich Plasma (PRP) Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Platelet Rich Plasma (PRP) Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Platelet Rich Plasma (PRP) Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Platelet Rich Plasma (PRP) Sales Breakdown by Type (2018-2023)
2 Global Platelet Rich Plasma (PRP) Market Competition by Company
2.1 Global Top Players by Platelet Rich Plasma (PRP) Sales (2018-2023)
2.2 Global Top Players by Platelet Rich Plasma (PRP) Revenue (2018-2023)
2.3 Global Top Players by Platelet Rich Plasma (PRP) Price (2018-2023)
2.4 Global Top Manufacturers Platelet Rich Plasma (PRP) Manufacturing Base Distribution, Sales Area, Product Type
2.5 Platelet Rich Plasma (PRP) Market Competitive Situation and Trends
2.5.1 Platelet Rich Plasma (PRP) Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Platelet Rich Plasma (PRP) Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Platelet Rich Plasma (PRP) as of 2022)
2.7 Date of Key Manufacturers Enter into Platelet Rich Plasma (PRP) Market
2.8 Key Manufacturers Platelet Rich Plasma (PRP) Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Platelet Rich Plasma (PRP) Status and Outlook by Region
3.1 Global Platelet Rich Plasma (PRP) Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Platelet Rich Plasma (PRP) Historic Market Size by Region
3.2.1 Global Platelet Rich Plasma (PRP) Sales in Volume by Region (2018-2023)
3.2.2 Global Platelet Rich Plasma (PRP) Sales in Value by Region (2018-2023)
3.2.3 Global Platelet Rich Plasma (PRP) Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Platelet Rich Plasma (PRP) Forecasted Market Size by Region
3.3.1 Global Platelet Rich Plasma (PRP) Sales in Volume by Region (2024-2029)
3.3.2 Global Platelet Rich Plasma (PRP) Sales in Value by Region (2024-2029)
3.3.3 Global Platelet Rich Plasma (PRP) Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Platelet Rich Plasma (PRP) by Application
4.1 Platelet Rich Plasma (PRP) Market Segment by Application
4.1.1 Orthopedic Surgery
4.1.2 Cosmetic Surgery
4.1.3 General Surgery
4.1.4 Other Surgeries
4.2 Global Platelet Rich Plasma (PRP) Market Size by Application
4.2.1 Global Platelet Rich Plasma (PRP) Market Size Overview by Application (2018-2029)
4.2.2 Global Platelet Rich Plasma (PRP) Historic Market Size Review by Application (2018-2023)
4.2.3 Global Platelet Rich Plasma (PRP) Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Platelet Rich Plasma (PRP) Sales Breakdown by Application (2018-2023)
4.3.2 Europe Platelet Rich Plasma (PRP) Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Platelet Rich Plasma (PRP) Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Platelet Rich Plasma (PRP) Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Platelet Rich Plasma (PRP) Sales Breakdown by Application (2018-2023)
5 North America Platelet Rich Plasma (PRP) by Country
5.1 North America Platelet Rich Plasma (PRP) Historic Market Size by Country
5.1.1 North America Platelet Rich Plasma (PRP) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Platelet Rich Plasma (PRP) Sales in Volume by Country (2018-2023)
5.1.3 North America Platelet Rich Plasma (PRP) Sales in Value by Country (2018-2023)
5.2 North America Platelet Rich Plasma (PRP) Forecasted Market Size by Country
5.2.1 North America Platelet Rich Plasma (PRP) Sales in Volume by Country (2024-2029)
5.2.2 North America Platelet Rich Plasma (PRP) Sales in Value by Country (2024-2029)
6 Europe Platelet Rich Plasma (PRP) by Country
6.1 Europe Platelet Rich Plasma (PRP) Historic Market Size by Country
6.1.1 Europe Platelet Rich Plasma (PRP) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Platelet Rich Plasma (PRP) Sales in Volume by Country (2018-2023)
6.1.3 Europe Platelet Rich Plasma (PRP) Sales in Value by Country (2018-2023)
6.2 Europe Platelet Rich Plasma (PRP) Forecasted Market Size by Country
6.2.1 Europe Platelet Rich Plasma (PRP) Sales in Volume by Country (2024-2029)
6.2.2 Europe Platelet Rich Plasma (PRP) Sales in Value by Country (2024-2029)
7 Asia-Pacific Platelet Rich Plasma (PRP) by Region
7.1 Asia-Pacific Platelet Rich Plasma (PRP) Historic Market Size by Region
7.1.1 Asia-Pacific Platelet Rich Plasma (PRP) Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Platelet Rich Plasma (PRP) Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Platelet Rich Plasma (PRP) Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Platelet Rich Plasma (PRP) Forecasted Market Size by Region
7.2.1 Asia-Pacific Platelet Rich Plasma (PRP) Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Platelet Rich Plasma (PRP) Sales in Value by Region (2024-2029)
8 Latin America Platelet Rich Plasma (PRP) by Country
8.1 Latin America Platelet Rich Plasma (PRP) Historic Market Size by Country
8.1.1 Latin America Platelet Rich Plasma (PRP) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Platelet Rich Plasma (PRP) Sales in Volume by Country (2018-2023)
8.1.3 Latin America Platelet Rich Plasma (PRP) Sales in Value by Country (2018-2023)
8.2 Latin America Platelet Rich Plasma (PRP) Forecasted Market Size by Country
8.2.1 Latin America Platelet Rich Plasma (PRP) Sales in Volume by Country (2024-2029)
8.2.2 Latin America Platelet Rich Plasma (PRP) Sales in Value by Country (2024-2029)
9 Middle East and Africa Platelet Rich Plasma (PRP) by Country
9.1 Middle East and Africa Platelet Rich Plasma (PRP) Historic Market Size by Country
9.1.1 Middle East and Africa Platelet Rich Plasma (PRP) Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Platelet Rich Plasma (PRP) Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Platelet Rich Plasma (PRP) Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Platelet Rich Plasma (PRP) Forecasted Market Size by Country
9.2.1 Middle East and Africa Platelet Rich Plasma (PRP) Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Platelet Rich Plasma (PRP) Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Harvest Technologies
10.1.1 Harvest Technologies Company Information
10.1.2 Harvest Technologies Introduction and Business Overview
10.1.3 Harvest Technologies Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Harvest Technologies Platelet Rich Plasma (PRP) Products Offered
10.1.5 Harvest Technologies Recent Development
10.2 DePuy Synthes
10.2.1 DePuy Synthes Company Information
10.2.2 DePuy Synthes Introduction and Business Overview
10.2.3 DePuy Synthes Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.2.4 DePuy Synthes Platelet Rich Plasma (PRP) Products Offered
10.2.5 DePuy Synthes Recent Development
10.3 Stryker
10.3.1 Stryker Company Information
10.3.2 Stryker Introduction and Business Overview
10.3.3 Stryker Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Stryker Platelet Rich Plasma (PRP) Products Offered
10.3.5 Stryker Recent Development
10.4 Zimmer Biomet
10.4.1 Zimmer Biomet Company Information
10.4.2 Zimmer Biomet Introduction and Business Overview
10.4.3 Zimmer Biomet Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Zimmer Biomet Platelet Rich Plasma (PRP) Products Offered
10.4.5 Zimmer Biomet Recent Development
10.5 Arthrex
10.5.1 Arthrex Company Information
10.5.2 Arthrex Introduction and Business Overview
10.5.3 Arthrex Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Arthrex Platelet Rich Plasma (PRP) Products Offered
10.5.5 Arthrex Recent Development
10.6 Exactech
10.6.1 Exactech Company Information
10.6.2 Exactech Introduction and Business Overview
10.6.3 Exactech Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Exactech Platelet Rich Plasma (PRP) Products Offered
10.6.5 Exactech Recent Development
10.7 Emcyte Corporation
10.7.1 Emcyte Corporation Company Information
10.7.2 Emcyte Corporation Introduction and Business Overview
10.7.3 Emcyte Corporation Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Emcyte Corporation Platelet Rich Plasma (PRP) Products Offered
10.7.5 Emcyte Corporation Recent Development
10.8 Arteriocyte
10.8.1 Arteriocyte Company Information
10.8.2 Arteriocyte Introduction and Business Overview
10.8.3 Arteriocyte Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Arteriocyte Platelet Rich Plasma (PRP) Products Offered
10.8.5 Arteriocyte Recent Development
10.9 Adilyfe
10.9.1 Adilyfe Company Information
10.9.2 Adilyfe Introduction and Business Overview
10.9.3 Adilyfe Platelet Rich Plasma (PRP) Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Adilyfe Platelet Rich Plasma (PRP) Products Offered
10.9.5 Adilyfe Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Platelet Rich Plasma (PRP) Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Platelet Rich Plasma (PRP) Industrial Chain Analysis
11.4 Platelet Rich Plasma (PRP) Market Dynamics
11.4.1 Platelet Rich Plasma (PRP) Industry Trends
11.4.2 Platelet Rich Plasma (PRP) Market Drivers
11.4.3 Platelet Rich Plasma (PRP) Market Challenges
11.4.4 Platelet Rich Plasma (PRP) Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Platelet Rich Plasma (PRP) Distributors
12.3 Platelet Rich Plasma (PRP) Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
